804845454 | PUO | 53934814 | | 2766636 | 9/16/2006 12:00:00 AM | transaminitis , CBD dilitation , pancreatic duct dilitation s/p stenting , s/p sphinterectomy | | DIS | Admission Date: 3/30/2006 Report Status: Discharge Date: 2/2/2006 ****** FINAL DISCHARGE ORDERS ****** MCGUFFEE , THOMAS J 021-75-25-6 J50 Room: Ren Sta Vi Ford Service: MED DISCHARGE PATIENT ON: 1/18/06 AT 02:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: ELLZEY , OREN R. , M.D. CODE STATUS: Full code DISPOSITION: Rehabilitation DISCHARGE MEDICATIONS: ENTERIC COATED ASPIRIN ( BABY ) ( ASPIRIN ENTERI... ) 162 MG PO DAILY LIPITOR ( ATORVASTATIN ) 10 MG PO DAILY Alert overridden: Override added on 1/18/06 by : POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &amp; ATORVASTATIN CALCIUM Reason for override: md aware CALCIUM CARBONATE ( 500 MG ELEMENTAL CA++ ) 500 MG PO TID NEXIUM ( ESOMEPRAZOLE ) 20 MG PO DAILY HYDROCHLOROTHIAZIDE 25 MG PO DAILY INSULIN 70/30 HUMAN 20 UNITS SC QAM AVAPRO ( IRBESARTAN ) 150 MG PO DAILY Alert overridden: Override added on 7/6/06 by : POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; IRBESARTAN POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; IRBESARTAN Reason for override: md Previous Alert overridden Override added on 7/6/06 by : POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; IRBESARTAN POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; IRBESARTAN Reason for override: aware Previous Alert overridden Override added on 10/30/06 by ALSPAUGH , KERRY Y. , M.D. POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; IRBESARTAN POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; IRBESARTAN Reason for override: aware Previous override reason: Override added on 10/30/06 by THEPBANTHAO , DARCI H. , M.D. on order for POTASSIUM CHLORIDE IMMED. 
REL. 
PO ( ref # 487614228 ) POTENTIALLY SERIOUS INTERACTION: IRBESARTAN &amp; POTASSIUM CHLORIDE Reason for override: md aware Previous override information: Override added on 10/30/06 by THEPBANTHAO , DARCI H. , M.D. on order for POTASSIUM CHLORIDE IV ( ref # 493463126 ) POTENTIALLY SERIOUS INTERACTION: IRBESARTAN &amp; POTASSIUM CHLORIDE Reason for override: md aware LEVAQUIN ( LEVOFLOXACIN ) 500 MG PO Q48H Food/Drug Interaction Instruction Administer iron products a minimum of 2 hours before or after a levofloxacin or ciprofloxacin dose dose If on tube feeds , please cycle ( hold 1 hr before to 2 hr after ) Take 2 hours before or 2 hours after dairy products. 
LOPRESSOR ( METOPROLOL TARTRATE ) 50 MG PO TID Starting Today ( 10/24 ) HOLD IF: HR&lt;55 OR SBP&lt;110 Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
PILOCARPINE 0.5% 2 DROP OS QID Starting Today ( 10/24 ) MULTIVITAMIN THERAPEUTIC ( THERAPEUTIC MULTIVI... ) 1 TAB PO DAILY VITAMIN E ( TOCOPHEROL-DL-ALPHA ) 400 UNITS PO DAILY ALPHAGAN ( BRIMONIDINE TARTRATE ) 1 DROP OU BID XALATAN ( LATANOPROST ) 1 DROP OU QPM DIET: House / Low chol/low sat. 
fat ACTIVITY: Walking as tolerated FOLLOW UP APPOINTMENT( S ): PCP as scheduled on 4/11 1:30 , Stent removal Dr Krinsky 7/20 1:30 endoscopy , GI Dr Cujas 8/10 9am , ALLERGY: NKA ADMIT DIAGNOSIS: abdominal pain PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) transaminitis , CBD dilitation , pancreatic duct dilitation s/p stenting , s/p sphinterectomy OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay DM , HTN , Esophageal Ca , glaucoma , PPM OPERATIONS AND PROCEDURES: OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) s/p ercp stenting and sphinterotomy on 9/17/06 BRIEF RESUME OF HOSPITAL COURSE: CC: Abd Pain / GNR bacteremia *** HPI: 88F w DM , HTN , s/p PPM , h/o esoph CA s/p resxn p/w acute onset diffuse abd pain , somewhat stronger in LLQ , sharp , a/w nausea. 
Pain worse with eating. 
Had loose BMs x 3-4 days , no fevers , some chills. 
No CP , no palps , chronic stable DOE. 
In ED , Abd CT , U/S , HIDA scan all unremarkble , but 2/4 BCx with GNRs , and was given Levo/Flagyl. 
*** PMH: DM , HTN , TIA/CVA , s/p esoph CA s/p resection , s/p PPM *** ALL: NKDA *** HOME MEDS: Lipitor 10 , Vit E 400 , Pilocarpine , Timolol , Insulin 70/30 20 QAM , HCTZ 25 , PPI , Lopressor 50 bid , Avapro , ASA *** PEx: T96.9 P56 140/46 Sats ok on RA. NAD. 
Lungs clear , RRR S1/S2. 
Abd S/ND. 
Very mild tenderness , somewhat localized over LLQ. 
Hyperactive BS. Ext WWP. 
NONTOXIC looking. 
*** STUDIES: Abd CT: GB wall thickening , dilatation of pancreatic duct. 
HIDA: neg for CBD dist RUQ U/S: GB sludge *** NOTABLE LABS: AST 1425 , ALT 1259 , AlkPhos 198 , TB 1.9 , Amy 90. Chem 7 / CBC unremarkable. 
No anion gap. 
BCx with 2/4 GNRs. 
*** A/P: 88F w abd pain of unclear etiology on admission with transaminitis , abd pain and suspected bile duct stones and sludge. 
Underwent ERCP which demonstrated dilated main pancreatitic duct s/p stenting , dilated CBD with sludge s/p sphinterectomy. 
Transaminitis and abd pain have continued to improve. 
*** ID: Given GNR bacteremia , emperically covered with Levo / Ceftaz. 
Cx grew pansensitive Kleb , and coverage was narrowed to Levo to complete a 14 day course. 
Surveillance cx negative. 
GI: Marked transaminitis. 
No recent new meds. 
Hepatitis serologies negative , U/S w Doppler to r/o Budd-Chiari esp given acute onset negative , Lactate + guaiac for ? 
mesenteric ischemia( but no gap )negative. 
No indication for surgery. 
GI consulted recommended ERC , results as above. 
LFTs trending down s/p sphinterotomy and ERCP. 
Will f/u with GI in 2 weeks for repeat ERCP at PUO . 
CV: Cont Lipitor , HCTZ , Lopressor , Avapro , ASA. 
No signs of ischemia , failure. 
Uptitrated avapro given persistent HTN , appears to be near maximally BB in terms of heart rate OPHTH: Cont eye drops ENDO: h/o DM , cont insulin + scale. 
FEN: Npo pending ercp , adv to clears s/p procedure well tolerated , K/Mg scales. 
Ppx: Nexium / Lovenox Full Code ADDITIONAL COMMENTS: DISCHARGE CONDITION: Stable TO DO/PLAN: *f/u with PCP and Gi as scheduled *return to ED with worsening symptoms of abd pain or if unable to tolera No dictated summary ENTERED BY: THEPBANTHAO , DARCI H. , M.D. ( HT541 ) 1/18/06 @ 02 ****** END OF DISCHARGE ORDERS ******